CurveBeam AI Limited (ASX:CUR)

Leveraging advanced AI to enhance diagnostic imaging in orthopedics and bone health.

About Us

Combining Weight Bearing CT (WBCT) imaging equipment with AI solutions to target faster, more efficient point of care clinical assessment aids in orthopaedics & bone health

Company Overview

CurveBeam AI is at the forefront of developing and manufacturing CT devices, particularly specializing in natural bilateral weight bearing CT technology aimed at improving visual assessments for diagnosing, prognosing, and managing orthopaedic and bone health issues. The company's corporate headquarters is located in Melbourne, with an operational base in Hatfield, PA, USA. CurveBeam AI has successfully raised around A$85 million in capital and employs over 50 staff across its Australian and US locations, supported by 18 regional distributors. Their product range includes both weight bearing and non-weight bearing CT devices, known for their advanced 3D scanning capabilities that enhance clinical assessments.

The company is actively developing cloud-based AI modules to assist doctors in diagnosis and surgical planning, addressing multibillion-dollar market opportunities, particularly in the US. These markets include a A$10 billion sector for Point of Care CT Imaging equipment and a A$4.1 billion per annum market for bone health, focusing on fracture prevention. CurveBeam AI forecasts a revenue of A$11 million for FY23, indicating a growth of approximately 49%, with 170 devices already placed globally in renowned medical institutions such as UCLA, Duke, and Mayo Clinic. Furthermore, the company has established a co-marketing and distribution agreement with the Foot & Ankle division of Stryker Corporation, significantly boosting its market presence with 38 placements of its leading HiRise device across orthopaedic practices in the US, EU, Australia, and other regions.

Board & Management

Greg Brown

Greg Brown

Chief Executive Officer & Managing Director

  • 35 years healthcare business experience in medical devices, IVD’s & theranostics.
  • International roles for Baxter Diagnostics (Australia & UK), Global Marketing Roche Molecular (Switzerland/New York), VP Global Marketing Digene Corp (DC/Germany) where he was part of the team that commercialised HPV DNA testing globally.
  • 2006-2012 ImpediMed (IPD), 2013 – 2021 StraxCorp (Chairman & CEO).
  • Board experience: Trinity Biotech (NASDAQ), ICS, CRC for Dx, Immunexpress (IXP), IPD(ASX), Minomic, UniQuest (UQ).
Arjun Singh

Arjun Singh

Executive Director

  • 34 years technology and business experience in medical imaging.
  • CurveBeam President & CEO (2009 – 2022). VP/CTO Imaging Sciences International (Hatfield/ Pennsylvania); key player in commercializing cone beam CT imaging for Dental/Maxillofacial applications.
  • Led development & introduction of I-CAT, with 9,000+ systems installed worldwide.
  • Arun was awarded a Lifetime Achievement Award by the AADMRT in 2016 for his visionary contributions to the advancement of cone beam CT.
Ura P Auckland

Ura P Auckland

Chief Financial Officer & Company Secretary

  • An experienced finance and commercial executive with nearly 20 years experience at the C-Level, mostly in scientific and medical early stage companies.
  • As a CFO he has led two successful Initial Public Offerings (IPOs) and stock exchange listings, and has extensive experience in capital raising pre and post listing, and has lead due diligence on many mergers and acquisitions including 4 across international borders.
CurveBeam AI Limited

Follow CurveBeam AI Limited

By submitting your information below you can keep up to date with their relevant news and announcements.

Fields marked with * are required.